No open-market selling at Ctt Pharmaceutical Holdings, Inc. in the past year, which is unusual. Instead one insiders added about $16,000 worth of CTTH.
CTT PHARMACEUTICAL HOLDINGS, INC. (Director) made the biggest buy, worth around $8,000. That includes C-suite money, which tends to get the most attention.
Quarter by quarter: Last full quarter: net buying by insiders. Insiders bought in 5 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 3,700 | $0.06 | $204 | SEC |
| Sep 29, 2026 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 10,100 | $0.05 | $505 | SEC |
| Sep 28, 2026 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 3,400 | $0.06 | $204 | SEC |
| Sep 22, 2026 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 10,100 | $0.05 | $505 | SEC |
| Sep 16, 2026 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 10,900 | $0.05 | $545 | SEC |
| Sep 10, 2026 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 3,500 | $0.05 | $175 | SEC |
| Sep 4, 2026 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 9,800 | $0.05 | $490 | SEC |
| Sep 2, 2026 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 3,000 | $0.05 | $150 | SEC |
| Aug 31, 2026 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 3,500 | $0.05 | $175 | SEC |
| Aug 24, 2026 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 2,100 | $0.06 | $126 | SEC |
| Aug 20, 2026 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 11,500 | $0.05 | $575 | SEC |
| Aug 19, 2026 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 10,000 | $0.06 | $600 | SEC |
| Aug 14, 2026 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 1,800 | $0.06 | $108 | SEC |
| Aug 10, 2026 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 7,700 | $0.07 | $539 | SEC |
| Dec 17, 2025 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Buy | 8,300 | $0.06 | $498 | SEC |
In the last 12 months Ctt Pharmaceutical Holdings, Inc. insiders made open-market purchases worth about $16,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CTTH was filed on 2026-10-06.
No congressional trades in CTTH were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).